跳至主要内容
临床试验/NCT05334758
NCT05334758已完成不适用

Clinical Performance Evaluation of the Bio-Self™ COVID-19 Antigen Home Test

BioTeke USA, LLC3 个研究点 分布在 1 个国家目标入组 282 人开始时间: 2022年5月12日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
282
试验地点
3
主要终点
Positive Percent Agreement - Sensitivity

研究概览

简要总结

The purpose of this study is to evaluate the performance of the Bio-Self COVID-19 Antigen Home Test. The study will evaluate the accuracy (sensitivity and specificity) in a simulated home use environment when compared to a high-sensitivity Emergency Use Authorization (EUA) SARS-CoV-2 RT-PCR assay.

详细描述

The Bio-Self COVID-19 Antigen Home Test is immunochromatographic and uses double-antibody sandwich method to detect SARS-CoV-2 antigen from individuals with or without symptoms or other epidemiological reasons to suspect a COVID-19 infection. The test is intended for non-prescription home use with self-collected direct anterior nares swab samples from individuals ages 14 years and older or adult collected anterior nares swab samples from individuals ages 2 to 13.

The primary objective of this study is to determine the accuracy of the Bio-Self COVID-19 Antigen Home Test when compared to a high-sensitivity Emergency Use Authorization (EUA) SARS-CoV-2 RT-PCR assay.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
2 Years 至 94 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •An Institutional Review Board (IRB) approved informed consent and assent, if applicable, is signed and dated prior to any study-related activities.
  • •Male and female Subjects 2 years of age and older.
  • •Subject is willing to provide a self-collected nasal swab sample. (If under the age of 14, the sample will be collected by an adult.)
  • •Subject is willing to have a nasal swab collected by a healthcare professional.
  • •Subject agrees to complete all aspects of the study.

排除标准

  • •Subject has a visual impairment that cannot be restored with glasses or contact lenses.
  • •Subject has prior medical or laboratory training.
  • •Subject had a positive COVID-19 test in past three (3) months.
  • •Subject uses home diagnostics, e.g., HIV Tests, glucose meters, etc.

研究组 & 干预措施

At least 30 children between 2 - 13 years of age

Experimental

Subjects less than 14 years of age, where the Parent or legal guardian collects a sample from their child (e.g., ages 2-13) and performs the Bio-Self COVID-19 antigen home test. The standard of care test and the RT-PCR test samples will be collected by the study team.

干预措施: Bio-Self COVID-19 Antigen Home Test (Device)

At least 30 children between 2 - 13 years of age

Experimental

Subjects less than 14 years of age, where the Parent or legal guardian collects a sample from their child (e.g., ages 2-13) and performs the Bio-Self COVID-19 antigen home test. The standard of care test and the RT-PCR test samples will be collected by the study team.

干预措施: Standard of Care COVID-19 Test (Device)

At least 30 children between 2 - 13 years of age

Experimental

Subjects less than 14 years of age, where the Parent or legal guardian collects a sample from their child (e.g., ages 2-13) and performs the Bio-Self COVID-19 antigen home test. The standard of care test and the RT-PCR test samples will be collected by the study team.

干预措施: RT-PCR Test (Diagnostic Test)

Subjects 14 - 90 years of age

Experimental

The subject will self collect and test using the Bio-Self COVID-19 antigen home test. The standard of care test and the RT-PCR test samples will be collected by the study team.

干预措施: Bio-Self COVID-19 Antigen Home Test (Device)

Subjects 14 - 90 years of age

Experimental

The subject will self collect and test using the Bio-Self COVID-19 antigen home test. The standard of care test and the RT-PCR test samples will be collected by the study team.

干预措施: Standard of Care COVID-19 Test (Device)

Subjects 14 - 90 years of age

Experimental

The subject will self collect and test using the Bio-Self COVID-19 antigen home test. The standard of care test and the RT-PCR test samples will be collected by the study team.

干预措施: RT-PCR Test (Diagnostic Test)

结局指标

主要结局

Positive Percent Agreement - Sensitivity

时间窗: 48 hours

The sensitivity is computed as the proportion of positive samples as called by the EUA SARS-CoV-2 RT-PCR assay, which are also positive as called by the Bio-Self COVID-19 Antigen Home Test.

Negative Percent Agreement - Specificity

时间窗: 48 hours

The specificity is computed as the proportion of negative samples as called by the EUA SARS-CoV-2 RT-PCR assay, which are also negative as called by the Bio-Self COVID-19 Antigen Home Test.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验

Clinical Performance Evaluation of the Bio-Self™... | 临床试验